Stifel Financial
CPRX

Stifel Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Stifel Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.38M Buy
217,151
+40,126
+23% +$956K ﹤0.01% 1308
2025
Q4 		$4.13M Buy
177,025
+76,993
+77% +$1.72M ﹤0.01% 1435
2025
Q3 		$1.97M Sell
100,032
-1,082
-1% -$22.3K ﹤0.01% 1928
2025
Q2 		$2.19M Buy
101,114
+83,515
+475% +$1.97M ﹤0.01% 1781
2025
Q1 		$427K Buy
+17,599
New +$396K ﹤0.01% 2791
2015
Q2 		– Sell
-35,000
Closed -$152K – 2364
2015
Q1 		$152K Buy
+35,000
New +$126K ﹤0.01% 2153

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Stifel Financial's CPRX Position: Q1 2026 in Review

Stifel Financial increased its Catalyst Pharmaceutical (CPRX) stake by 23% in Q1 2026, buying an estimated $956K and bringing the position to 217,151 shares worth $5.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Stifel Financial first reported a position in CPRX in Q1 2015 and has held it in 6 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Stifel Financial held 217,151 shares of Catalyst Pharmaceutical worth $5.38M as of Q1 2026.
  • Stifel Financial bought 40,126 Catalyst Pharmaceutical shares in Q1 2026, an estimated $956K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #1308 holding.
  • Stifel Financial first reported a position in Catalyst Pharmaceutical in Q1 2015 and has held it in 6 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.